Department of Health and Human Services June 22, 2017 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2017-13070
Type: Notice
Date: 2017-06-22
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Center for Substance Abuse Treatment; Notice of Meeting
Document Number: 2017-13054
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Treatment; Notice of Meeting
Document Number: 2017-13051
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Proposed Information Collection Activity; Comment Request
Document Number: 2017-13033
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services, Administration for Children and Families
Agency Information Collection Activities; Submission for OMB Review; Comment Request; Revision of a Currently Approved Collection (ICR Rev); National Survey of Older Americans Act Participants (NSOAAP)
Document Number: 2017-13030
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services
The Administration for Community Living (ACL) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance as required under the Paperwork Reduction Act of 1995 (the PRA). This 30-Day notice collects comments on the information collection requirements related to a Revision of a Currently Approved Collection (ICR Rev) (OMB approval number 0985-0023).
National Committee on Vital and Health Statistics: Meeting
Document Number: 2017-13023
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services
Agency Information Collection Activities: Submission to OMB for Review and Approval; Information Collection Request Title: Rural Health Network Development Planning Performance Improvement and Measurement System Database, OMB No. 0915-0384-Extension
Document Number: 2017-13019
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
In compliance with the Paperwork Reduction Act of 1995, HRSA has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Potential Tobacco Product Violations Reporting Form
Document Number: 2017-13018
Type: Notice
Date: 2017-06-22
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Proposed Information Collection Activity; Comment Request
Document Number: 2017-13017
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services, Administration for Children and Families
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Document Number: 2017-12981
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Document Number: 2017-12980
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2017-12979
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2017-12978
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2017-12977
Type: Notice
Date: 2017-06-22
Agency: Department of Health and Human Services, National Institutes of Health
Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access; Public Meeting; Request for Comments
Document Number: 2017-12641
Type: Notice
Date: 2017-06-22
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) is announcing the following meeting: ``The Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access.'' This public meeting is intended to provide the public an opportunity to submit comments concerning administration of the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act (FD&C Act) to help ensure the intended balance between encouraging innovation in drug development and accelerating the availability to the public of lower cost alternatives to innovator drugs is maintained.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.